Viral Hepatitis C - SciClone says drug misses trial targets, shares plunge

SciClone says drug misses trial targets, shares plunge
Reuters - said its experimental drug Zadaxin to treat Hepatitis C infection did not show statistically significant results in

ViRexx to Present Hepatitis C Vaccine Data at HepDART 2005
Business Wire UK - PM US Eastern Timezone ViRexx to Present Hepatitis C Vaccine Data at HepDART 2005 EDMONTON, Alberta pre-clinical data from a hepatitis C Chimigen(TM) vaccine candidate will

Severe liver disease will increase unless injecting drug users are tested and treated
British Medical Journal - Computer illustration of a hepatitis C virus, which is now carried by 200 000 people in England Credit of its annual reports on hepatitis C the agency estimates that about